These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8317066)

  • 21. [Research for resistance media to Cycloserine. II. The influences of the preservative method of media and the preservative period on the minimal inhibitory concentration of Cycloserine to Mycobacterium tuberculosis].
    Tamura M; Takano S
    Iryo; 1966 Jun; 20(6):573-8. PubMed ID: 4960848
    [No Abstract]   [Full Text] [Related]  

  • 22. [Approaches to combined therapy of pulmonary tuberculosis in adolescents excreting drug-resistant Mycobacterium tuberculosis].
    Firsova VA; Rusakova LI; Grigor'eva ZP; Ryzhova AP; Iatskova TV; Poluéktova FG
    Probl Tuberk; 2001; (1):28-30. PubMed ID: 11337776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Results of 30 year follow-ups of pulmonary tuberculosis patients contingent with isolated drug resistant or sensitive strains].
    Zhukova MP
    Probl Tuberk; 1997; (5):12-5. PubMed ID: 9454239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Significance of mycobacterial drug resistance in pulmonary tuberculosis surgery].
    Repin IuM; Avetisian AO; El'kin AV; Otten TF; Riasnianskaia TE; Trofimov MA
    Probl Tuberk; 2001; (9):6-10. PubMed ID: 11858098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Within-host population dynamics of antibiotic-resistant M. tuberculosis.
    Alavez-Ramírez J; Castellanos JR; Esteva L; Flores JA; Fuentes-Allen JL; García-Ramos G; Gómez G; López-Estrada J
    Math Med Biol; 2007 Mar; 24(1):35-56. PubMed ID: 17060491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Blood bacteriostatic activity in patients with respiratory tuberculosis].
    Manicheva OA; Vishnevskiĭ BI; Ivanova LI; Pavlova MV; Archakova LI
    Probl Tuberk; 2001; (8):24-6. PubMed ID: 11767384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Drug sensitivity in Mycobacterium tuberculosis versus its viability, cytotoxicity, genotype, and the course of the process in patients with pulmonary tuberculosis].
    Manicheva OA; Lasunskaia EB; Zhuravlev VIu; Otten TF; Barnaulov AO; Mokrousov IV; Pavlova MV; Vishnevskiĭ BI; Narvskaia OV
    Probl Tuberk Bolezn Legk; 2008; (12):18-22. PubMed ID: 19230183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Beta-lactam inhibitors of beta-lactamases in Mycobacterium].
    Galán JC
    Rev Esp Quimioter; 1998 Dec; 11(4):386-8. PubMed ID: 10336326
    [No Abstract]   [Full Text] [Related]  

  • 29. [Impact of drug resistance on the fitness of Mycobacteruim tuberculosis of the genotype W-Beijing].
    Tungusova OS; Mar'iandyshev AO; Kaugant DA; Sandven P; Bjeune G
    Probl Tuberk Bolezn Legk; 2005; (8):46-50. PubMed ID: 16209021
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug resistant tuberculosis in Estonia.
    Kruuner A; Sillastu H; Danilovitsh M; Levina K; Svenson SB; Källenius G; Hoffner SE
    Int J Tuberc Lung Dis; 1998 Feb; 2(2):130-3. PubMed ID: 9562123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can studies of the early bactericidal activity of rifapentine tell us how to prevent acquired rifamycin-resistant relapse?
    Wallis RS
    Am J Respir Crit Care Med; 2005 Jul; 172(1):4-5. PubMed ID: 15980108
    [No Abstract]   [Full Text] [Related]  

  • 32. [Some problems of chemotherapy in tuberculosis in view of the results of culture of resected foci of pulmonary tuberculosis].
    Kameda K
    Kekkaku; 1967 Jun; 42(6):197-202. PubMed ID: 4965993
    [No Abstract]   [Full Text] [Related]  

  • 33. [Drug resistance of Mycobacterium tuberculosis and its significance in the hospital practice].
    Rudoĭ NM
    Probl Tuberk; 1996; (3):6-8. PubMed ID: 8754863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Some epidemiological and clinical aspects of primary resistance to the classic drugs in patients with pulmonary tuberculosis].
    Zierski M
    Tuberkuloza; 1966; 18(1-3):300-6. PubMed ID: 16296101
    [No Abstract]   [Full Text] [Related]  

  • 35. [Surveillance of primary resistance in 481 cases of pulmonary tuberculosis].
    Zhen X; Yao L; Peng Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Jun; 22(6):362-3. PubMed ID: 11775828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the resistance ratio and proportion methods for antimicrobial susceptibility testing of Mycobacterium tuberculosis.
    Tansuphasiri U; Subpaiboon S; Rienthong S
    J Med Assoc Thai; 2001 Oct; 84(10):1467-76. PubMed ID: 11804258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Occurence of primary resistance in hospital patients with respiratory tuberculosis].
    Serdarević H; Bogdanović M; Travnik H; Simeonov L
    Tuberkuloza; 1966; 18(1-3):220-7. PubMed ID: 16296090
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug resistance pulmonary tuberculosis in the Eastern Province of Saudi Arabia.
    Al-Rubaish AM; Madania AA; Al-Muhanna FA
    Saudi Med J; 2001 Sep; 22(9):776-9. PubMed ID: 11590451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High rates of multidrug-resistant Mycobacterium tuberculosis in Sinaloa State, Mexico.
    Zazueta-Beltran J; Muro-Amador S; Flores-Gaxiola A; Llausas-Magaña E; León-Sicairos N; Canizalez-Roman A
    J Infect; 2007 Apr; 54(4):411-2. PubMed ID: 16730800
    [No Abstract]   [Full Text] [Related]  

  • 40. [Immunological studies in the treatment of tuberculosis with flureniside].
    Sibirnaia RI
    Probl Tuberk; 1997; (5):27-8. PubMed ID: 9454246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.